Adaptix is transforming planar X-ray by giving it true 3D capability, making it safer by reducing dose (versus CT, and potentially versus planar X-ray), making the systems 50% cheaper than existing market offerings and reducing weight and size by 90%. By doing this we will be improving access to the world’s most important medical diagnostic device and radically changing a £5bn global market.
Phone: 01865 309619
Animal Dynamics Limited
Animal Dynamics Limited is a spinout company from the Department of Zoology at Oxford University. The company is setting out to develop a portfolio of products derived from research into evolutionary adaptations in flight, swimming, walking, and stealth, where nature has arrived at significant performance optimizations which can be applied to commercial products.
Phone: 01865 309695
A biopharmaceutical company focused exclusively on discovering, developing and commercialising orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. Chemocentryx’s HQ is in California with a virtual office at BSP.
Chiralabs provides specialist consultancy, research and analytical services for investigating molecular products in the pharmaceutical, biotechnology and chemical industries. Chiralabs has been at BSP since 2006 and has customers across the site.
Phone: 01865 854810
Oxford Gene Technology (OGT)
Molecular genetics company delivering solutions to leading clinical and academic research institutions. Founded by Professor Sir Edwin Southern in 1995, OGT has an increasing share of the expanding genomic medicine market with customers in over 60 countries worldwide.
Phone: +44 1865 856800
Particle Therapeutics Ltd
Our first product is a single-use needle-free delivery device pre-filled with glucagon particles. This device will offer emergency delivery of glucagon to individuals with diabetes who are experiencing extremely low blood sugar levels (severe hypoglycaemia).
Phone: 01865 854 893
Population Diagnostics UK, Inc.
Phone: +44 7825 408322
Ian Thompson investigates the role of micro-organisms including the development of bioreactors for treating industrial effluent, metal recovery and water recycling, and exploitation of microbial-nanomaterial interactions for killing water-borne pathogens.
Nanoparticles for Cancer Therapy
Contact: Dr Helen Townley
Telephone: +44 1865 283792
This interdisciplinary group, involving the Nuffield Department of Obstetrics and Gynaecology and nanoscientists from the Department of Engineering Science, led by Dr Helen Townley, focuses on the use of nanoparticles in cancer therapy, imaging or drug delivery.